Genzyme reborn as Sanofi-Genzyme Korea

Published: 2016-02-23 16:00:14

Updated: 2016-02-23 16:00:14

A pharmaceutical company specializing in rare diseases, Genzyme has been re-born as a Sanofi Group’s ‘Sanofi Genzyme’ department.

According to the industry concerned on the 19^th, the Sanofi’s Korean branch confirmed the business reorganization, combined anticancer products and Genzyme products, such as ‘Taxotere(docetaxel),’ and established a specialty business department on February.

The dec...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.